Phospholipid model membranes. I. Structural characteristics of hydrated liquid crystals - PubMed (original) (raw)

Phospholipid model membranes. I. Structural characteristics of hydrated liquid crystals

D Papahadjopoulos et al. Biochim Biophys Acta. 1967.

No abstract available

PubMed Disclaimer

Similar articles

• Phospholipid model membranes. II. Permeability properties of hydrated liquid crystals.
  Papahadjopoulos D, Watkins JC. Papahadjopoulos D, et al. Biochim Biophys Acta. 1967 Sep 9;135(4):639-52. doi: 10.1016/0005-2736(67)90095-8. Biochim Biophys Acta. 1967. PMID: 6048247 No abstract available.
• Surface properties of acidic phospholipids: interaction of monolayers and hydrated liquid crystals with uni- and bi-valent metal ions.
  Papahadjopoulos D. Papahadjopoulos D. Biochim Biophys Acta. 1968 Sep 17;163(2):240-54. doi: 10.1016/0005-2736(68)90103-x. Biochim Biophys Acta. 1968. PMID: 4301073 No abstract available.
• Hexagonal packing of lipid acyl chains and membrane plasticity.
  Dorset DL, Hui SW, Storzewski CM. Dorset DL, et al. J Supramol Struct. 1976;5(1):1-14. doi: 10.1002/jss.400050102. J Supramol Struct. 1976. PMID: 994499
• Polymorphic phase behaviour of phospholipid membranes studied by infrared spectroscopy.
  Casal HL, Mantsch HH. Casal HL, et al. Biochim Biophys Acta. 1984 Dec 4;779(4):381-401. doi: 10.1016/0304-4157(84)90017-0. Biochim Biophys Acta. 1984. PMID: 6391546 Review. No abstract available.
• Membrane interaction and deformation.
  Parsegian VA, Rand RP. Parsegian VA, et al. Ann N Y Acad Sci. 1983;416:1-12. doi: 10.1111/j.1749-6632.1983.tb35175.x. Ann N Y Acad Sci. 1983. PMID: 6375506 Review.

Cited by

• pH-triggered pore-forming peptides with strong composition-dependent membrane selectivity.
  Kim SY, Bondar AN, Wimley WC, Hristova K. Kim SY, et al. Biophys J. 2021 Feb 16;120(4):618-630. doi: 10.1016/j.bpj.2021.01.010. Epub 2021 Jan 16. Biophys J. 2021. PMID: 33460594 Free PMC article.
• Antimicrobial Peptide K11 Selectively Recognizes Bacterial Biomimetic Membranes and Acts by Twisting Their Bilayers.
  Ramos-Martín F, Herrera-León C, Antonietti V, Sonnet P, Sarazin C, D'Amelio N. Ramos-Martín F, et al. Pharmaceuticals (Basel). 2020 Dec 22;14(1):1. doi: 10.3390/ph14010001. Pharmaceuticals (Basel). 2020. PMID: 33374932 Free PMC article.
• Enhanced Efficacy of PEGylated Liposomal Cisplatin: In Vitro and In Vivo Evaluation.
  Ghaferi M, Asadollahzadeh MJ, Akbarzadeh A, Ebrahimi Shahmabadi H, Alavi SE. Ghaferi M, et al. Int J Mol Sci. 2020 Jan 15;21(2):559. doi: 10.3390/ijms21020559. Int J Mol Sci. 2020. PMID: 31952316 Free PMC article.
• Use of transethosomes for enhancing the transdermal delivery of olmesartan medoxomil: in vitro, ex vivo, and in vivo evaluation.
  Albash R, Abdelbary AA, Refai H, El-Nabarawi MA. Albash R, et al. Int J Nanomedicine. 2019 Mar 15;14:1953-1968. doi: 10.2147/IJN.S196771. eCollection 2019. Int J Nanomedicine. 2019. PMID: 30936696 Free PMC article.
• An intrinsic lipid-binding interface controls sphingosine kinase 1 function.
  Pulkoski-Gross MJ, Jenkins ML, Truman JP, Salama MF, Clarke CJ, Burke JE, Hannun YA, Obeid LM. Pulkoski-Gross MJ, et al. J Lipid Res. 2018 Mar;59(3):462-474. doi: 10.1194/jlr.M081307. Epub 2018 Jan 11. J Lipid Res. 2018. PMID: 29326159 Free PMC article.

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Elsevier Science

• Other Literature Sources

  • The Lens - Patent Citations